Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PARP1 | P09874 | 2/20 | 0.56 |
| ▸ | MAPT | P10636 | 4/20 | 0.42 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.42 |
| ▸ | APEX1 | P27695 | 1/20 | 0.42 |
| ▸ | RECQL | P46063 | 1/20 | 0.42 |
| ▸ | BLM | P54132 | 1/20 | 0.42 |
| ▸ | BRD4 | O60885 | 1/20 | 0.41 |
| ▸ | DPP4 | P27487 | 1/20 | 0.41 |
| ▸ | MEN1 | O00255 | 3/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.41 |
| ▸ | POLB | P06746 | 2/20 | 0.41 |
| ▸ | GAA | P10253 | 1/20 | 0.41 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.41 |
| ▸ | PNP | P00491 | 1/20 | 0.40 |
| ▸ | DRD4 | P21917 | 3/20 | 0.40 |
| ▸ | DRD3 | P35462 | 3/20 | 0.40 |
| ▸ | PRKCI | P41743 | 1/20 | 0.39 |
| ▸ | PRNP | P04156 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL13387352 | 0.98 | PARP1 (0.55) | PARP1MAPTTDP1ALDH1A1KDM4E | |
| Hydrochloric Acid SCHEMBL5456659 | 0.98 | PARP1 (0.55) | PARP1MAPTTDP1ALDH1A1KDM4E | |
| SCHEMBL20878376 | 0.77 | BRD4 (0.56) | PARP1MAPTALDH1A1BRD4DPP4 | |
| SCHEMBL3171067 | 0.76 | PARP1 (0.52) | PARP1MAPTALDH1A1BRD4DPP4 | |
| SCHEMBL28267894 | 0.74 | PARP1 (0.61) | PARP1KDM4EHPGD | |
| SCHEMBL8667 | 0.74 | PARP1 (0.56) | PARP1MAPTALDH1A1BRD4MEN1 | |
| SCHEMBL13857864 | 0.74 | PARP1 (0.50) | PARP1MAPTALDH1A1BRD4DPP4 | |
| SCHEMBL900151 | 0.74 | MEN1 (0.52) | PARP1MAPTALDH1A1BRD4DPP4 | |
| SCHEMBL196738 | 0.74 | PARP1 (0.56) | PARP1MAPTALDH1A1BRD4DPP4 | |
| SCHEMBL1261706 | 0.74 | PARP1 (0.55) | PARP1MAPTALDH1A1BRD4DPP4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1143 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12630851-B2 | Polynucleotide modification methods | OXFORD NANOPORE TECHNOLOGIES PLC (GB) | 2026-05-19 | — | — | US | claimed |
| US-12624387-B2 | Method for reducing primer dimer formation and increasing amplification efficiency | SEEGENE, INC. (KR) | 2026-05-12 | — | — | US | claimed |
| US-12584168-B2 | Sample preparation method | OXFORD NANOPORE TECHNOLOGIES PLC (GB) | 2026-03-24 | — | — | US | claimed |
| US-12371736-B2 | TD probe and its uses | SEEGENE, INC. (KR) | 2025-07-29 | — | — | US | claimed |
| CN-119978548-A | Ammonium polyphosphate flame retardant and preparation method and application thereof | 青岛科技大学 | 2025-05-13 | — | — | CN | claimed |
| CN-119735921-A | Basalt fiber reinforced anti-falling mobile phone shell and preparation method thereof | 安徽简星科技有限公司 | 2025-04-01 | — | — | CN | claimed |
| CN-118874529-A | Efficient glass fiber denitration catalyst and preparation method and application thereof | 安徽通普材料科技有限公司 | 2024-11-01 | — | — | CN | claimed |
| WO-2024163380-A1 | SUBSTITUTED BENZIMIDAZOLE COMPOUNDS USEFUL AS INHIBITORS OF TLR9 | BRISTOL-MYERS SQUIBB COMPANY (US) | 2024-08-08 | — | — | WO | claimed |
| WO-2024136630-A1 | METHOD FOR SEQUENCE HOMOLOGY SEARCH OF NUCLEOTIDE DATABASE | 주식회사 씨젠 | 2024-06-27 | — | — | WO | claimed |
| CN-117181990-B | High-temperature-resistant precoated sand and preparation method thereof | 胜利油田金岛实业有限责任公司 | 2024-03-19 | — | — | CN | claimed |
| EP-0599703-B1 | Use of 4-hydroxy- or 4-aminobenzumidazol or their derivatives as coupler agent in oxidative dye compositions, the compositions and its method of application | OREAL (FR) | 1997-09-17 | — | — | EP | claimed |
| EP-0728464-B1 | Composition for dyeing keratinous fibers comprising a diaminopyrazole derivative and a heterocyclic coupleur and dyeing process | OREAL (FR) | 1997-07-30 | — | — | EP | claimed |
| EP-0605320-B1 | Dye composition for keratinic fibres based on paraphenylenediamine, metaphenylenediamines and benzimidazol derivates, and the dyeing process using same | OREAL (FR) | 1997-04-09 | — | — | EP | claimed |
| US-5578087-A | Dyeing compositions for keratinous fibres based on para-phenylene-diamines, meta-phenylenediamine and benzimidazole derivatives, and dyeing process employing them | L'OREAL (FR) | 1996-11-26 | — | — | US | claimed |
| EP-0728464-A1 | Composition for dyeing keratinous fibers comprising a diaminopyrazole derivative and a heterocyclic coupleur and dyeing process | L'OREAL (FR) | 1996-08-28 | — | — | EP | claimed |
| EP-0728466-A1 | Keratinous fibers oxidation dyeing composition comprising an oxidation base, an indolic coupler and an additional heterocyclic coupler and dyeing process | L'OREAL (FR) | 1996-08-28 | — | — | EP | claimed |
| US-5494490-A | DYEING KERATINOUS FIBERS BY APPLYING AS COUPLER 4-HYDROXY- OR 4-AMINOBENZIMIDAZOLE OR THEIR DERIVATIVES IN PRESENCE OF PARA-PHENYLENEDIAMINE OR ITS DERIVATIVES | L'OREAL (FR) | 1996-02-27 | — | — | US | claimed |
| EP-0605320-A1 | Dye composition for keratinic fibres based on paraphenylenediamine, metaphenylenediamines and benzimidazol derivates, and the dyeing process using same | L'OREAL (FR) | 1994-07-06 | — | — | EP | claimed |
| EP-0599703-A1 | Use of 4-hydroxy- or 4-aminobenzumidazol or their derivatives as coupler agent in oxidative dye compositions, the compositions and its method of application | L'OREAL (FR) | 1994-06-01 | — | — | EP | claimed |
| US-4662905-A | REACTION PRODUCT OF COPPER SALT AND AN IMIDAZOLE, PYRAZOLE, TRIAZOLE, OR TETRAZOLE | Itaru Todoriki, Director of Agency of Industrial Science and Technology (JP) | 1987-05-05 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12584168-B2 | Sample preparation method | POLN, POLRMT, POLM | PARP1 53/4885MAPT 3486/4885TDP1 302/4885 |
| US-12630851-B2 | Polynucleotide modification methods | PNP, NT5C3B, UNG | PARP1 155/4885MAPT 3328/4885TDP1 206/4885 |
| US-12624387-B2 | Method for reducing primer dimer formation and increasing amplification efficiency | UBR4, UBAP2, UBAP2L | PARP1 385/4885MAPT 547/4885TDP1 2389/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.